When used for acute CVA, tPA is associated with symptomatic intracranial hemorrhage at a rate of approximately 6%.35,36 However, when tPA is given to those with healthy brains, the rate of such hemorrhage is much lower.37 This evidence concerns the gene PLAT and intracranial hemorrhage.